February 12, 2026 · Form 4 insider transaction
Boyer David W. bought 1,600 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.